Brazil

 

At $2.4bn, Rede D’Or IPO would be emerging market hospital record

Brazil's largest private hospital chain Rede D'Or's December 10 IPO could raise US$2.4bn, which would make it the largest emerging market hospital listing ever and second overall. That is despite the fact 2020 revenue is flat and net profit is down 80% due to COVID-19.

Emerging market lab roundup

HBI rounds up the latest news from the world's largest emerging market laboratories, including Grupo Fleury in Brazil striking a deal with a rival, and lab activity normalising in India.

Diaverum to IPO in Stockholm as Saudi JV buyout boosts EBITA

Global renal care group Diaverum's upcoming Stockholm IPO has 'strong international and Swedish investor interest', CEO Dimitris Moulavasilis tells HBI, as the market reaches historic highs. We talk expansion and diversification plans and 2020 performance. 

CVC “frontrunner to buy Eugin”

HBI hears that CVC is frontrunner to buy international IVF chain Eugin as parent company NMC Health's administrators Alvarez and Marsal looks to complete a lender-led sale of the group by Spring 2021.

Integrated model ‘alive and kicking’ despite Banmedica closures

Greater scrutiny is being brought to bear on the use of integrated models in Chile - a practice where any impropriety is sidestepped through the use of holding companies. Where does this leave the likes of UnitedHealth Group-owned Banmedica, which has just closed four health centres in its Vidaintegra network - and why is public concern mounting about private insurers profits?

Veritas Intercontinental raises €5m as it off-shoots from ailing US business

Veritas Intercontinental, the spin-off of US genome sequencing group, Veritas Genetics, has raised €5m from existing investors to help finish building a new lab in Spain. CEO Javier de Echevarría tells HBI that the money will help to establish its independence from its former parent company which temporarily ceased US trading last year. 

Hapvida and Intermedica continue M&A binge through crisis

Brazilian listed HMOs (health management organisations) Hapvida Saude and Grupo Notre Dame Intermedica have resumed their M&A binge since July after a quiet second quarter, despite the pandemic continuing to rage throughout the country. 

Rede d’Or hires banks for $2.7bn IPO

Rede d'Or, Brazil's largest hospital chain by revenue, has reportedly hired banks to prepare a long-awaited $2.7bn IPO for the autumn. The company reportedly expects a valuation of $17.8bn, which would make it the second-largest listed hospital group in the world by market capitalisation after HCA.

Find Us